Loading...
Market
First major manufacturer to finalize a pre-approval mpox vaccine deal by end of 2024?
2
Resolution / Starting Odds
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Official announcements from WHO, Gavi, UNICEF, or the manufacturers
Story
WHO Allows Pre-Approval Mpox Vaccine Purchases for Low-Income Nations
Aug 23, 2024, 11:32 AM
The World Health Organization (WHO) has announced that its partners, including Gavi and UNICEF, can begin negotiations to purchase mpox vaccines before they receive official approval. This decision is aimed at facilitating the distribution of vaccines to low-income nations, ensuring they have access to necessary medical supplies. The move is part of a broader strategy to address public health needs promptly, especially in regions that may face challenges in accessing vaccines post-approval.
View original story
Similar markets
Moderna • 25%
Pfizer • 25%
AstraZeneca • 25%
Other • 25%
Company A • 25%
Company B • 25%
Company C • 25%
Other • 25%
Democratic Republic of the Congo • 25%
South Africa • 25%
Kenya • 25%
Uganda • 25%
United States • 25%
China • 25%
European Union • 25%
Other • 25%
Company A • 25%
Company B • 25%
Company C • 25%
Other • 25%
Yes • 50%
No • 50%
1-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
16+ countries • 25%
United States • 25%
European Union • 25%
Africa • 25%
Other • 25%
